CALC Stock Summary and Trading Ideas (Calcimedica | NASDAQ:CALC)

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

What symbol and exchange does Calcimedica shares trade?

Calcimedica trades on the NASDAQ stock market under the symbol CALC.

What is Calcimedica stock price doing today?

As of June 16, 2026, CALC stock price declined to $0.86 with 65,773 million shares trading.

What is Calcimedica's Beta?

CALC has a beta of 0.24, meaning it tends to be less sensitive to market movements. CALC has a correlation of 0.00 to the broad based SPY ETF.

How much is Calcimedica worth?

CALC has a market cap of $13.59 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Calcimedica traded in the last 3 year period?

In the last 3 years, CALC traded as high as $8.38 and as low as $.46.

What are the top ETFs holding Calcimedica?

The top ETF exchange traded funds that CALC belongs to (by Net Assets): VXF.

Is Calcimedica (CALC) a good investment?

CALC has underperformed the market in the last year with a return of -50.0%, while the SPY ETF gained +27.7%. In the last 3 month period, CALC fell short of the market, returning +3.6%, while SPY returned +14.3%. However, in the most recent 2 weeks CALC has outperformed the stock market by returning +2.1%, while SPY returned -0.5%.

What are the support and resistance levels for Calcimedica (CALC)?

CALC support price is $.79 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CALC shares will trade within this expected range on the day.